Acute Investment Advisory’s Innovator US Equity Ultra Buffer ETF January UJAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-491,697
Closed -$14.6M 19
2022
Q4
$14.6M Buy
491,697
+323,568
+192% +$9.56M 9.96% 4
2022
Q3
$4.91M Buy
168,129
+11,977
+8% +$353K 3.52% 8
2022
Q2
$4.55M Buy
156,152
+4,654
+3% +$139K 3.53% 10
2022
Q1
$4.69M Buy
+151,498
New +$4.66M 3.5% 9

Other funds holding UJAN

Acute Investment Advisory's UJAN Position: Q1 2023 in Review

Acute Investment Advisory sold out of Innovator US Equity Ultra Buffer ETF January (UJAN) in Q1 2023, closing a stake of 491,697 shares — an estimated $14.6M sold.

Acute Investment Advisory first reported a position in UJAN in Q1 2022 and held it in 4 quarters. The position peaked at $14.6M in Q4 2022. 77 funds tracked by Wall St. Rank hold UJAN as of Q1 2023.

  • Acute Investment Advisory reported no remaining Innovator US Equity Ultra Buffer ETF January position as of Q1 2023 after selling out during the quarter.
  • Acute Investment Advisory sold 491,697 Innovator US Equity Ultra Buffer ETF January shares in Q1 2023, an estimated $14.6M.
  • Acute Investment Advisory first reported a position in Innovator US Equity Ultra Buffer ETF January in Q1 2022 and held it in 4 quarters.
  • Acute Investment Advisory's Innovator US Equity Ultra Buffer ETF January position peaked at $14.6M in Q4 2022.
  • 77 funds tracked by Wall St. Rank held Innovator US Equity Ultra Buffer ETF January as of Q1 2023.

Based on Acute Investment Advisory's 13F filing for Q1 2023, filed 21 Apr 2023.